Van Lanschot Kempen NV

-0.7% €56.7

17:30 – 14/03/2026

Nieuws van Van Lanschot Kempen NV

Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update

Bron: GlobeNewswire

Autheur: Oculis Holding AG

Gepubliceerd op: 2026-03-03

ZUG, Switzerland, March 3, 2026 — Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (Oculis), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in ophthalmology and neuro-ophthalmology, today announce…

Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update

Bron: GlobeNewswire

Autheur: Oculis Holding AG

Gepubliceerd op: 2026-03-03

ZUG, Switzerland, March 03, 2026 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (Oculis), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in ophthalmology and neuro-ophthalmolo…

Oculis birtir uppgjör fyrir fjórða ársfjórðung og árið 2025 og kynnir áfanga í rekstri félagsins

Bron: GlobeNewswire

Autheur: Oculis Holding AG

Gepubliceerd op: 2026-03-03

ZUG, Sviss, March 03, 2026 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS / XICE: OCS) („Oculis“), alþjóðlegt líftæknifyrirtæki með áherslu á nýsköpun til að mæta brýnni þörf fyrir meðferðir við augnsjúkdómum og augntaugasjúkdómum, birti í dag uppgjör fyr…

Scroll naar boven